Market Report - Europe Close
European shares ended on a mixed note on Wednesday as bank-driven gains in the morning were lost.
European shares powered ahead on Tuesday, driven by Covid-19 vaccine hopes, optimism around the transition of the US presidency and takeover news in Scandinavia.
European shares pared early gains on Monday even after positive news around AstraZeneca's Covid-19 vaccine.
European stocks were firmer at the end of the week and heading into the Thanksgiving holidays Stateside, although some analysts appeared to be decisively cautious.
European shares were lower at midday as investors fretted over rising coronavirus deaths in Japan, the US and on the Continent.
European shares finished the session on a mixed note as some investors took profits and the euphoria over test results from a second Covid-19 vaccine fizzled out.
European markets started the week on a bullish note after US biotechnology outfit Moderna delivered another dose of good news, announcing a remarkable 94. 5% efficacy for its Covid-19 vaccine.
European shares finished a week of rampant gains on a positive note, helped by reports that the second wave of Covid-19 cases in Belgium and France might be breaking.
European shares slipped on Thursday as nervous investors took profits after three days of solid gains.
European shares continued to make gains on Wednesday as investors remained optimistic about a potential Covid-19 vaccine from Pfizer and and BioNTech, despite the rising number of cases across the Continent.
European shares added to Monday's sharp gains after EU lawmakers agreed to the outlines of the bloc's next long-term budget.
European shares bounded higher, led by Spanish and French issues, after Pfizer and BioNTech said their Covid-19 vaccine candidate prevented more than 90% of infections in a study of tens of thousands of volunteers, paving the way for emergency use.
European equities were stuck in a rut on Friday as investors awaited the outcome of the US election and warily watched the continued spread of Covid-19 infections.
European shares continued to gain altitude on Thursday as Joe Biden inched towards the White House although the count in key states continued amid threats of legal challenges by President Donald Trump.
European shares recovered from early morning drop to trade sharply higher, despite no clear outcome in the US presidential election as of yet and weak industry data across the euro zone suggesting a double dip recession.
European stocks continued to move higher at the start of November, brushing aside concerns about new Covid-19 lockdowns and turning their attention to the US elections.
European shares bounced back at the start of the week as better-than-expected reading on factory sector activity out of China, India and the US helped to steady investor sentiment.
European stocks finished the session mostly higher after what one economist termed a "bittersweet" print on third quarter Eurozone gross domestic product.
Stocks on the Continent ended the session little changed as investors chose to sit on their hands ahead of a barrage of earnings results from US tech giants Apple, Amazon and Facebook which were scheduled for release after the close of trading on Wall Street.
European shares finished sharply lower amid reports of impending coronavirus lockdowns in France and Germany dampened sentiment.